Kidney dosimetry in [ 177 Lu]Lu-DOTA-TATE therapy based on multiple small VOIs

被引:0
|
作者
Kapidzic, Selma Curkic [1 ,2 ,3 ]
Gustafsson, Johan [1 ]
Larsson, Erik [2 ]
Jessen, Lovisa [1 ]
Gleisner, Katarina Sjogreen
机构
[1] Lund Univ, Med Radiat Phys, Lund, Sweden
[2] Skane Univ Hosp, Dept Hematol Oncol & Radiat Phys, Radiat Phys, Malmo, Sweden
[3] Skanes Univ Sjukhus, Barngatan 4, S-22185 Lund, Sweden
关键词
177; Lu-PRRT; Quantitative SPECT; Dosimetry; Kidneys; RECEPTOR RADIONUCLIDE THERAPY; PATIENT-SPECIFIC DOSIMETRY; IMAGE-BASED DOSIMETRY; NEUROENDOCRINE TUMORS; SPECT; ACCELERATION;
D O I
10.1016/j.ejmp.2024.103335
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The aim was to investigate the use of multiple small VOIs for kidney dosimetry in [ 177 Lu]Lu-DOTA-TATE therapy. Method: The study was based on patient and simulated SPECT images in anthropomorphic geometries. Images were reconstructed using two reconstruction programs (local LundaDose and commercial Hermia) using OS -EM with and without resolution recovery (RR). Five small VOIs were placed to determine the average activity concentration (AC) in each kidney. The study consisted of three steps: (i) determination of the number of iterations for AC convergence based on simulated images; (ii) determination of recovery -coefficients (RCs) for 2 mL VOIs using a separate set of simulated images; (iii) assessment of operator variability in AC estimates for simulated and patient images. Five operators placed the VOIs, using for guidance: a) SPECT/CT with RR, b) SPECT/CT without RR, and c) CT only. For simulated images, time -integrated ACs (TIACs) were evaluated. For patient images, estimated ACs were compared with results of a previous method based on whole -kidney VOIs. Results: Eight iterations and ten subsets were sufficient for both programs and reconstruction settings. Mean RCs (mean +/- SD) with RR were 1.03 +/- 0.02 (LundaDose) and 1.10 +/- 0.03 (Hermia), and without RR 0.91 +/- 0.03 (LundaDose) and 0.94 +/- 0.03 (Hermia). Most stable and accurate estimates of the AC were obtained using five 2mL VOIs guided by SPECT/CT with RR, applying them to images without RR, and including an explicit RC for recovery correction. Conclusion: The small VOI method based on five 2-mL VOIs was found efficient and sufficiently accurate for kidney dosimetry in [ 177 Lu]Lu-DOTA-TATE therapy.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Efficacy of [177Lu]Lu-DOTA-TATE in metastatic neuroendocrine neoplasms of different locations: our experience.
    Pudis, M.
    Vercher-Conejero, J. L.
    Martin-Marcuartu, J. J.
    Teule-Vega, A.
    Bondia-Bescos, S.
    Hervas-Sanz, B.
    Rodriguez-Gasen, A.
    Diaz-Moreno, J.
    Cortes-Romera, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S647 - S647
  • [42] A PBPK model for PRRT with [177Lu]Lu-DOTA-TATE: Comparison of model implementations in SAAM II and MATLAB/SimBiology
    Vasic, Valentina
    Gustafsson, Johan
    Nowshahr, Elham Yousefzadeh
    Stenvall, Anna
    Beer, Ambros J.
    Glatting, Gerhard
    Gleisner, Katarina Sjogreen
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2024, 119
  • [43] Distinct In Vitro Binding Profile of the Somatostatin Receptor Subtype 2 Antagonist [177Lu]Lu-OPS201 Compared to the Agonist [177Lu]Lu-DOTA-TATE
    Mansi, Rosalba
    Plas, Pascale
    Vauquelin, Georges
    Fani, Melpomeni
    PHARMACEUTICALS, 2021, 14 (12)
  • [44] Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma
    Minczeles, Noemie S.
    Bos, Eelke M. M.
    de Leeuw, Reinoud C. C.
    Kros, Johan M. M.
    Konijnenberg, Mark W. W.
    Bromberg, Jacoline E. C.
    de Herder, Wouter W. W.
    Dirven, Clemens M. F.
    Hofland, Johannes
    Brabander, Tessa
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (04) : 1195 - 1204
  • [45] Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma
    Noémie S. Minczeles
    Eelke M. Bos
    Reinoud C. de Leeuw
    Johan M. Kros
    Mark W. Konijnenberg
    Jacoline E. C. Bromberg
    Wouter W. de Herder
    Clemens M. F. Dirven
    Johannes Hofland
    Tessa Brabander
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1195 - 1204
  • [46] Correlations between [68Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [177Lu]Lu-DOTA-TATE
    Bruvoll, Ragnar
    Blakkisrud, Johan
    Mikalsen, Lars Tore
    Connelly, James
    Stokke, Caroline
    CANCERS, 2023, 15 (04)
  • [47] Clinical implementation of PLANET® Dose for dosimetric assessment after [177Lu]Lu-DOTA-TATE: comparison with Dosimetry Toolkit® and OLINDA/EXM® V1.0
    Lore Santoro
    L. Pitalot
    D. Trauchessec
    E. Mora-Ramirez
    P. O. Kotzki
    M. Bardiès
    E. Deshayes
    EJNMMI Research, 11
  • [48] Clinical implementation of PLANET® Dose for dosimetric assessment after [177Lu]Lu-DOTA-TATE: comparison with Dosimetry Toolkit® and OLINDA/EXM® V1.0
    Santoro, Lore
    Pitalot, L.
    Trauchessec, D.
    Mora-Ramirez, E.
    Kotzki, P. O.
    Bardies, M.
    Deshayes, E.
    EJNMMI RESEARCH, 2021, 11 (01)
  • [49] Estimation of kidney doses from [177Lu]Lu-DOTA-TATE PRRT using single time point post-treatment SPECT/CT
    Spink, Safia
    Gillett, Daniel
    Heard, Sarah
    Harper, Ines
    Casey, Ruth
    Aloj, Luigi
    EJNMMI PHYSICS, 2024, 11 (01):
  • [50] Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [177Lu]Lu-DOTA-TATE therapy
    Gubbi, Sriram
    Al-Jundi, Mohammad
    Auh, Sungyoung
    Jha, Abhishek
    Zou, Joy
    Shamis, Inna
    Meuter, Leah
    Knue, Marianne
    Turkbey, Baris
    Lindenberg, Liza
    Mena, Esther
    Carrasquillo, Jorge A.
    Teng, Yating
    Pacak, Karel
    Klubo-Gwiezdzinska, Joanna
    Del Rivero, Jaydira
    Lin, Frank I.
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14